Effect of Corticosteroid Injection on Supratip Skin Thickness in Rhinoplasty. Other hypertrophic disorders of skin
Conditions
Interventions
Intervention 1: Intervention Group: After completion of the surgical procedure, 10 mg of triamcinolone is injected into the supratip area of patients in the experimental group following wound closure
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 53 Years
Inclusion criteria
Inclusion criteria: All patients admitted for rhinoplasty in the plastic surgery department who provided informed consent Their supratip skin thickness measured by ultrasound exceeds 3.1 millimeters
Exclusion criteria
Exclusion criteria: Patient and Companions' Dissatisfaction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Supratip skin thickness. Timepoint: All patients will undergo preoperative ultrasound examination to assess supratip skin thickness prior to rhinoplasty. Patients with a supratip skin thickness greater than 3.1 millimeters will be included in the study. Postoperative measurements of supratip skin thickness will be performed in the second, fourth, and sixth weeks using high-frequency (10 MHz) superficial ultrasound probes by a radiologist. Method of measurement: Patients will be randomly assigned to two groups: those receiving triamcinolone and those not receiving it. The final assessment of the corticosteroid's effect on the nasal supratip area will be conducted through ultrasound imaging and evaluation of the injection site using the surgeon’s Visual Analog Scale (VAS) scores. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Abbas Ghaheri
Ahvaz University of Medical Sciences
Outcome results
None listed